Skip to content

Agnimukha churna and hamsapadadi vati in the management of subclinical hypothyroidism

Efficacy of Agnimukha Churna and Hamsapadadi Vati in the Managememt of Subclinical Hypothyroidism-an open labelled randomized standard controlled clinical trail - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081097
Enrollment
30
Registered
2025-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients aged between 18-60 years of either gender. 2)Newly diagnosed or previously diagnosed patient of TSH level 4.32-10mlU/L. 3)Patients having no symptoms or few symptoms of subclinical hypothyroidism like tiredness, weakness, dry skin, cold intolerance, hair loss, constipation, weight gain with poor appetite, and menstrual abnormalities. 4)Patients willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1)Serum TSH level more than 10mIU/L and less than 4.32mIU/L 2)Patient taking allopathic medication for subclinical hypothyroidism. 3)Patients suffering from any other systemic illness viz. with a known case of uncontrolled Diabetes (Random blood sugar more than 200mg/dl), uncontrolled Hypertension (systolic blood pressure more than 140mmHg or diastolic blood pressure more than 90 mmHg), Psychiatric disorders, cardiovascular events, cerebrovascular event, malignancy. 4)Patients suffering from secondary hypothyroidism, Hashimoto s thyroiditis. 5)Pregnant and lactating patients. 6)Patients aged below 18 years and above 60 years of either sex.

Design outcomes

Primary

MeasureTime frame
Reduction in the serum TSH levelTimepoint: 60 days

Secondary

MeasureTime frame
a) Improvement in symptoms of subclinical hypothyroidism. b) Improvement in Agni c) Improvement in the quality of life (Modified quality of life scale of thyroid) Timepoint: 60 days

Countries

India

Contacts

Public ContactDr Sushmita Ninganure

Institute of Teaching and Research in Ayurveda Jamnagar

csmehta@itra.edu.in9428862264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026